PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-09-27

Date Title Company
27-Sep-2022 ABIVAX ABSTRACT ON OBEFAZIMOD PHASE 2B RESULTS SELECTED FOR MODERATED POSTER PRESENTATION AT UEG WEEK 2022 ABIVAX
27-Sep-2022 Nemaura and EVERSANA sign preliminary agreement for large-scale launch of Nemaura’s Diabetes Management Program in the U.S. EVERSANA
27-Sep-2022 Kepler Vision Technologies expands into Spain with three psychiatric hospital deployments Kepler Vision Technologies
27-Sep-2022 Myeloma diagnosis can take over 5 months and require more than 4 medical consultations with up to 3 different specialists Myeloma Patients Europe
27-Sep-2022 Quanticate partners with Cancer Research UK to launch DETERMINE Study Quanticate
27-Sep-2022 Fagron launches excipients line DiluCap - making capsule formulation easier and more reliable Fagron
27-Sep-2022 SME competition offers Franklin expertise for research challenge The Rosalind Franklin Institute
27-Sep-2022 Tezspire approved for a broad population of patients with severe asthma with no phenotype or biomarker limitations AstraZeneca
27-Sep-2022 Sosei Heptares to host R&D Day highlighting its innovative R&D and translational medicine approaches to drug discovery and strong pipeline momentum Sosei Heptares
27-Sep-2022 Interim results for the six months ended 30 June 2022 BenevolentAI
27-Sep-2022 R&D Day: Presentations to Highlight Transgene’s Competitive Positioning, Capabilities to Engineer Novel Immunotherapies for Patients with Cancer, and Update on Initial Clinical Data Transgene
27-Sep-2022 Prosoma Digital Therapeutics and EVERSANA Announce Commercialisation Partnership for New Therapeutic Supporting Mental Health and Behavioural Needs of Cancer Patients Prosoma Digital Therapeutics
27-Sep-2022 Creative BioMart Released One-stop Algal Expression Services Creative BioMart
27-Sep-2022 E-prescribing (e-Rx) Market Future Aspect Analysis and Current Trends by 2016 to 2030 We Market Research
27-Sep-2022 Catheter-Directed Thrombolysis Market is projected to be valued at US$ 432.0 Million in 2022 MARKITWIRED
27-Sep-2022 Cholesterol API Market size is expected to reach a valuation of US$ 269.0 Million by the end of 2022 MARKITWIRED
27-Sep-2022 Dry Eye Syndrome Treatment Market to around US$ 8.84 Billion by 2031 MARKITWIRED
27-Sep-2022 Dosimetry Market is expected to reach US$ 4.3 Billion by the end of 2029 MARKITWIRED
27-Sep-2022 Veterinary Vaccines Market is projected to witness a CAGR of nearly 7% From (2022–2026). MARKITWIRED
27-Sep-2022 Surface Plasmon Resonance Market is estimated to reach US$ 1.5 Billion by 2029 MARKITWIRED